I also think the FDA approval is not a game changer (since the so called " Bronchitol business restructure" did not happen) for the share price, unless Chiesi can do a magical sale figure in US market.
There is a chance, although remote, that the LOXL2 deal can be announced. But 2+ years already since Gary Philips bragging the drug has drawn huge interests from big pharams, I doubt this is going to happen at all.
Bone cancer is a new, cool and fancy story, which I guess will last a year or two for these guys enjoying the shareholders' money for their salary and bonus,
Show the deal and show the money Gary, or you are nothing but a liar.
I also think the FDA approval is not a game changer (since the...
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.68M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $30.40K | 1.594M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 843043 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1080275 | 5 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.9¢ |
Change
0.000 ( 5.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.0¢ | 2.0¢ | 1.9¢ | 141350 | ||
| Last updated 15.46pm 24/05/2024 ? | |||||
| SNT (ASX) Chart |